Jamie Widawsky
Medical · Mineola, NYNPI 1780943076
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (45.0%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. It is spread thinly across 18 manufacturers, the largest accounting for just 16.8%. 2025 is the largest year on record at $12,861, 5.0 times the $2,597 reported in 2021. Among medical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 379 payments — averaging $95.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$6K
- LEO Pharma Inc.$5K
- AbbVie$5K
- Eli Lilly$4K
- Regeneron Healthcare Solutions, Inc.$4K
- Galderma Laboratories, L.p.$2K
- plus $11K from 12 others
What the payments were for
- Consulting fees$16,37545%
- Speaking & faculty fees$3,0148%
- Travel & lodging$9733%
- Food & beverage$15,45842%
- Education$5562%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 25 | $6,119 |
| LEO Pharma Inc. | 41 | $5,409 |
| AbbVie | 86 | $4,617 |
| Eli Lilly | 4 | $4,054 |
| Regeneron Healthcare Solutions, Inc. | 43 | $3,672 |
| Galderma Laboratories, L.p. | 19 | $1,849 |
| Sanofi | 34 | $1,621 |
| Johnson & Johnson | 20 | $1,590 |
| Novartis | 4 | $1,556 |
| Dermavant Sciences, Inc. | 20 | $1,508 |
| Arcutis Biotherapeutics, Inc. | 21 | $1,489 |
| Incyte Corporation | 33 | $1,141 |
| E.r. Squibb & Sons, L.L.C. | 17 | $852 |
| Organon | 2 | $355 |
| Amgen | 6 | $325 |
| Regeneron | 1 | $123 |
| VYNE Pharmaceuticals Inc. | 1 | $53 |
| UCB, Inc. | 2 | $43 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$36,375 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 49 | $342,465 |
| Dupixent PenDupilumab | 78 | $289,671 |
| OtezlaApremilast | 17 | $80,033 |
| Doxycycline Ir-DrDoxycycline Monohydrate | 21 | $15,902 |
| ZoryveRoflumilast | 11 | $9,187 |
| Tacrolimus | 30 | $1,871 |
| Doxycycline Hyclate | 38 | $1,086 |
| Desonide | 19 | $983 |
| Ciclopirox | 13 | $784 |
| Desloratadine | 20 | $748 |
| Fluorouracil | 14 | $712 |
| Clobetasol Propionate | 14 | $597 |
| Fluocinolone Acetonide | 18 | $541 |
| Hydroxychloroquine Sulfate | 16 | $330 |
| Gabapentin | 29 | $201 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AmgenOtezla | $325 | $80,03317 claims |
| Arcutis Biotherapeutics, Inc.Zoryve | $1,489 | $9,18711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,395 medical providers in New York.
Other medical in Mineola
- Abim SharmaMineola$23K
- Michael DylagMineola$14K
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.